Jiangsu Aidea Pharmaceutical Group Co., Ltd. develops, produces, and sells pharmaceutical products. The company offers anti-HIV products; ainuovirine tablets; urinary protein products, including crude product/intermediate of ulinastatin, urinary kallidinogenase, and urokinase; sennae folium granules; and baicillus cereus tablets. It also exports its products. The company was formerly known as Jiangsu Aidea Pharmaceutical Co., Ltd. and changed its name to Jiangsu Aidea Pharmaceutical Group Co., Ltd. in July 2025. The company was founded in 2009 and is headquartered in Yangzhou, China.
Metrics to compare | 688488 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship688488PeersSector | |
---|---|---|---|---|
P/E Ratio | −56.6x | −15.1x | −0.5x | |
PEG Ratio | 1.69 | 0.29 | 0.00 | |
Price/Book | 6.4x | 6.3x | 2.6x | |
Price / LTM Sales | 12.1x | 19.5x | 3.2x | |
Upside (Analyst Target) | - | −0.1% | 41.9% | |
Fair Value Upside | Unlock | −18.1% | 4.3% | Unlock |